DK1629009T3 - Sammensætninger omfattende store og små bindefragmenter af antistoffer rettet imod det samme toksin - Google Patents

Sammensætninger omfattende store og små bindefragmenter af antistoffer rettet imod det samme toksin

Info

Publication number
DK1629009T3
DK1629009T3 DK04735923.7T DK04735923T DK1629009T3 DK 1629009 T3 DK1629009 T3 DK 1629009T3 DK 04735923 T DK04735923 T DK 04735923T DK 1629009 T3 DK1629009 T3 DK 1629009T3
Authority
DK
Denmark
Prior art keywords
compositions
directed against
binding fragments
antibodies directed
toxin
Prior art date
Application number
DK04735923.7T
Other languages
English (en)
Inventor
Jane Louise Holley
Carl Nicholas Mayers
David Whitfield
Timothy John Gilby Brooks
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of DK1629009T3 publication Critical patent/DK1629009T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04735923.7T 2003-06-03 2004-06-03 Sammensætninger omfattende store og små bindefragmenter af antistoffer rettet imod det samme toksin DK1629009T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0312642.2A GB0312642D0 (en) 2003-06-03 2003-06-03 Pharmaceutical composition
PCT/GB2004/002351 WO2004106376A1 (en) 2003-06-03 2004-06-03 Compositions comprising large and small binding fragments of antibodies against the same toxin

Publications (1)

Publication Number Publication Date
DK1629009T3 true DK1629009T3 (da) 2012-05-29

Family

ID=9959179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04735923.7T DK1629009T3 (da) 2003-06-03 2004-06-03 Sammensætninger omfattende store og små bindefragmenter af antistoffer rettet imod det samme toksin

Country Status (8)

Country Link
US (1) US7618625B2 (da)
EP (1) EP1629009B8 (da)
JP (1) JP5065677B2 (da)
AT (1) ATE549355T1 (da)
AU (1) AU2004242760B2 (da)
DK (1) DK1629009T3 (da)
GB (1) GB0312642D0 (da)
WO (1) WO2004106376A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563874B2 (en) 1998-08-31 2009-07-21 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
EP2153848A3 (en) 2005-01-27 2010-07-21 The Regents of the University of California Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins
WO2008041012A1 (en) * 2006-10-06 2008-04-10 The Secretary Of State For Defence Pharmaceutical composition comprising antibodies against a toxin
GB2442466A (en) * 2006-10-06 2008-04-09 Secr Defence Method of producing antibodies against toxins
WO2009008916A2 (en) 2007-03-22 2009-01-15 The Regents Of The University Of Californina Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US9000131B2 (en) 2008-07-31 2015-04-07 The Regents Of The University Of California Antibodies that neutralize botulinum neurotoxins
US9243057B2 (en) 2010-08-31 2016-01-26 The Regents Of The University Of California Antibodies for botulinum neurotoxins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040384A1 (en) * 2001-11-05 2003-05-15 Board Of Regents, The University Of Texas System Recombinant antibodies for the detection and neutralization of anthrax toxin
US20050042775A1 (en) * 2003-08-21 2005-02-24 Nicholas Pomato Botulinum antitoxin compositions and methods

Also Published As

Publication number Publication date
US20070036805A1 (en) 2007-02-15
ATE549355T1 (de) 2012-03-15
EP1629009B8 (en) 2012-04-18
JP2007527372A (ja) 2007-09-27
GB0312642D0 (en) 2003-07-09
JP5065677B2 (ja) 2012-11-07
US7618625B2 (en) 2009-11-17
WO2004106376A1 (en) 2004-12-09
EP1629009A1 (en) 2006-03-01
EP1629009B1 (en) 2012-03-14
AU2004242760A1 (en) 2004-12-09
AU2004242760B2 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
NO20063569L (no) M-CSF-spesifikt monoklonalt antistoff og anvendelse derav
EA200970210A1 (ru) Prlr-специфическое антитело и его применения
CY1119416T1 (el) Αντισωματα εναντι των τοξινων toy clostridium difficile (κλωστηριδιο το δυσκολο) και χρησεις εξ' αυτων
MX2022011958A (es) Conjugados de anticuerpo degradador y métodos de uso de los mismos.
GEP20094829B (en) Fully human antibodies against human 4-1bb (cd137)
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
WO2003033654A3 (en) Direct targeting binding proteins
WO2005026209A3 (en) Monoclonal antibodies against hmgb1
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
BRPI0408317A (pt) anticorpos do receptor de igf-i para o tratamento de cáncer
WO2023169896A8 (en) BINDING MOLECULES AGAINST FRα
EP2153848A3 (en) Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
DK1479696T3 (da) Humant monoklonalt antistof, der binder til Ep-CAM, og dets anvendelse ved cancerterapi
WO2007016285A3 (en) M-csf specific monoclonal antibody and uses thereof
WO2008019326A3 (en) Ephb3-specific antibody and uses thereof
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
DK1629009T3 (da) Sammensætninger omfattende store og små bindefragmenter af antistoffer rettet imod det samme toksin
WO2021207948A9 (en) Anti-sars-cov-2 antibodies and uses thereof
ECSP055849A (es) Anticuerpo ("11c7") anti-nogo a y su uso farmacéutico
NO20080649L (no) Forbindelser omfattende DMXAA for behandling av kreft
WO2004032832A3 (en) Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
WO2024031009A3 (en) Anti-cd24 antibodies and uses thereof